SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 30, 2003
Anika Therapeutics, Inc.
(Exact Name of Registrant as Specified in Its Charter)
|
Massachusetts |
|
000-21326 |
|
04-3145961 |
|||
|
(State or Other Jurisdiction
of |
|
(Commission
file |
|
(I.R.S. Employer Identification No.) |
|||
|
|
|
|
|
|
|||
|
160 New Boston Street, Woburn, Massachusetts |
|
|
01801 |
||||
|
(Address of Principal Executive Offices) |
|
|
(Zip Code) |
||||
|
|
|
|
|
||||
|
Registrant’s Telephone Number, Including Area Code: (781) 932-6616 |
|||||||
ITEM 7: FINANCIAL STATEMTENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
Exhibit 99.1 — Press Release of Anika Therapeutics, Inc. dated July 30, 2003.
ITEM 9: REGULATION FD DISCLOSURE.
This Form 8-K is being furnished to report information pursuant to Item 12 - Results of Operations and Financial Conditions in accordance with the interim guidance provided by the SEC pursuant to SEC Release No. 33-8216 and 34-47583. On July 30, 2003, Anika Therapeutics, Inc. issued a press release (“Press Release”) announcing its financial results for the second quarter of 2003. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in Woburn, Massachusetts on July 30, 2003.
|
|
ANIKA THERAPEUTICS, INC. |
||
|
|
|
||
|
July 30, 2003 |
By: |
/s/ Charles H. Sherwood |
|
|
|
|
Charles H. Sherwood, Ph.D. |
|
3
Exhibit Index
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press Release of Anika Therapeutics, Inc. dated July 30, 2003 |
4